To increase the efficacy of treatment, scientists from Virginia Tech’s College of Engineering have created a novel cancer immunotherapy that targets cancer-killing cytokines where they are found in tumours.
Immunotherapy
Novel immunotherapies like CAR T-cell therapies may not be effective in treating aggressive types of blood cancer due to a unique mutation in the cancer cells.
